Citius Pharmaceuticals is trading 12.11% up at $0.65 after rebounding from several volatile sessions.
- Shares declined 25.62% on August 17 and fell 4.13% on August 24.
- No new company-specific announcement dated August 25, 2026, was identified.
- The latest major release was the August 14 fiscal third-quarter update, while broader-market support appears insufficient to establish a clear catalyst.